Intravascular ultrasound developer EndoSonics has reached an agreement in principle with the Cordis division of Johnson & Johnson to end that company's role as exclusive distributor of certain EndoSonics products in the U.S., Europe, the Middle East,
Intravascular ultrasound developer EndoSonics has reached an agreement in principle with the Cordis division of Johnson & Johnson to end that company's role as exclusive distributor of certain EndoSonics products in the U.S., Europe, the Middle East, and Africa. Assuming completion of a definitive agreement, EndoSonics will launch its own distribution strategy, which will consist of direct sales in some locations, as well as alliances with regional distributors, according to the Rancho Cordova, CA-based firm.
EndoSonics made the move to terminate the Cordis relationship in response to declines in orders from the company in recent quarters. Despite several initiatives by both companies to increase sales, the firms have mutually decided to end the distribution relationship, said Reinhard Warnking, EndoSonics president and CEO.
In other EndoSonics news, the company reported revenue of $9 million in its first quarter (end-March), an increase of 42.6% compared with the $6.3 million reported in the same period last year. The firm reported a net loss of $1.1 million, however, compared with a profit of $505,000 posted in the first quarter of 1997.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.